Correlation Between Canntab Therapeutics and Aion Therapeutic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Canntab Therapeutics and Aion Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canntab Therapeutics and Aion Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Canntab Therapeutics Limited and Aion Therapeutic, you can compare the effects of market volatilities on Canntab Therapeutics and Aion Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canntab Therapeutics with a short position of Aion Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canntab Therapeutics and Aion Therapeutic.

Diversification Opportunities for Canntab Therapeutics and Aion Therapeutic

-0.17
  Correlation Coefficient

Good diversification

The 3 months correlation between Canntab and Aion is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Canntab Therapeutics Limited and Aion Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aion Therapeutic and Canntab Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canntab Therapeutics Limited are associated (or correlated) with Aion Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aion Therapeutic has no effect on the direction of Canntab Therapeutics i.e., Canntab Therapeutics and Aion Therapeutic go up and down completely randomly.

Pair Corralation between Canntab Therapeutics and Aion Therapeutic

Assuming the 90 days horizon Canntab Therapeutics is expected to generate 2.11 times less return on investment than Aion Therapeutic. But when comparing it to its historical volatility, Canntab Therapeutics Limited is 1.19 times less risky than Aion Therapeutic. It trades about 0.07 of its potential returns per unit of risk. Aion Therapeutic is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.37  in Aion Therapeutic on August 26, 2024 and sell it today you would earn a total of  0.68  from holding Aion Therapeutic or generate 183.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Canntab Therapeutics Limited  vs.  Aion Therapeutic

 Performance 
       Timeline  
Canntab Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Canntab Therapeutics Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental drivers remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Aion Therapeutic 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aion Therapeutic are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, Aion Therapeutic reported solid returns over the last few months and may actually be approaching a breakup point.

Canntab Therapeutics and Aion Therapeutic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Canntab Therapeutics and Aion Therapeutic

The main advantage of trading using opposite Canntab Therapeutics and Aion Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canntab Therapeutics position performs unexpectedly, Aion Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aion Therapeutic will offset losses from the drop in Aion Therapeutic's long position.
The idea behind Canntab Therapeutics Limited and Aion Therapeutic pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Commodity Directory
Find actively traded commodities issued by global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios